<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04041908</url>
  </required_header>
  <id_info>
    <org_study_id>BL42</org_study_id>
    <nct_id>NCT04041908</nct_id>
  </id_info>
  <brief_title>Use of a Medical Food in Adults Undergoing Surgery</brief_title>
  <official_title>Observation of the Use of a Medical Food in Older Adults Undergoing Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multi-center, prospective, one arm study to evaluate the addition of a medical food to the
      standard of care in elderly adults undergoing a surgical procedure.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Low enrollment
  </why_stopped>
  <start_date type="Actual">March 13, 2020</start_date>
  <completion_date type="Actual">April 10, 2020</completion_date>
  <primary_completion_date type="Actual">April 10, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Product Compliance</measure>
    <time_frame>Study Day 1 to Study Day 30</time_frame>
    <description>Percent of required study product intake from subject completed intake questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Investigator Wound Assessment</measure>
    <time_frame>Study Day 1 to Study Day 30</time_frame>
    <description>Percent of patients with complete wound healing based on physician assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Participant Wound Assessment Questionnaire</measure>
    <time_frame>Study Day 14 and Study Day 30</time_frame>
    <description>Participant completed 4 questions related to wound healing experience; 3 Likert-type questions scaled from 1-10 in negative direction; 1 dichotomous scale question</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Product Evaluation Questionnaire</measure>
    <time_frame>Study Day 30/Exit</time_frame>
    <description>Participant completed questionnaire; 4 Likert-type questions scaled from 1 - 9 in the negative direction; 2 Likert-type questions scaled from 1 - 5 in the negative direction</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Compliance, Patient</condition>
  <arm_group>
    <arm_group_label>Experimental Product</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drink mix powder</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Experimental Product</intervention_name>
    <description>2 sachets per day</description>
    <arm_group_label>Experimental Product</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant is scheduled to have non-melanoma skin cancer on either the head, leg,
             trunk and arm removed with final wound size of 1.0 to &lt; 5.0 cm in diameter or with 1.0
             &lt; 5.0 cm long axis if not circular that will be healed by secondary intent

          -  Participant has an acceptable state of health and nutrition

          -  Participant agrees not to begin taking any new medications, dietary supplements, or
             alternative therapies during the study period

          -  Participant is interested in participating in the study, willing to comply with the
             study protocol, and willing to consume two servings of drink mix per day according to
             the protocol

          -  Participant has voluntarily signed and dated an informed consent form (ICF), approved
             by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) and provided
             Health Insurance Portability and Accountability (HIPAA) authorization prior to any
             study participation

        Exclusion Criteria:

          -  Participant has a disease or condition that could interfere with the assessment of
             safety and efficacy of the study treatment and compliance of the participant with
             study visits/procedures

          -  Participant has type 1 diabetes mellitus or uncontrolled type 2 diabetes mellitus

          -  Participant has known immunosuppression

          -  Participant has platelet or coagulation disorders

          -  Therapy with another investigational agent within 30 days of Visit 1 that has not been
             approved

          -  Systemic infection at the time of enrollment in the study

          -  Currently receiving or have received recombinant human platelet-derived growth factor
             or similar therapies, or other bioengineered tissue therapy within the previous 4
             weeks

          -  Participant has an allergy or intolerance to any ingredient in the study product

          -  Participant is taking nutritional supplement(s)/capsules/formulas for wound healing
             and is unwilling to discontinue therapy for the duration of the study

          -  Participation in another clinical study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Nelson, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ClinOhio Research Services</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>July 30, 2019</study_first_submitted>
  <study_first_submitted_qc>July 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2019</study_first_posted>
  <last_update_submitted>April 29, 2020</last_update_submitted>
  <last_update_submitted_qc>April 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

